Wilson's disease;Wilsonova bolest

Acta Medica Croatica

Volumn 57, Issue 3, 2003, Pages 227-235

  Kovačević, Igor ^a,b   Zekan, Mirta ^a,b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Copper metabolism; Diagnosis; Treatment; Wilson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CERULOPLASMIN; CHELATING AGENT; COPPER; PENICILLAMINE; TETRATHIOMOLYBDATE AMMONIUM; TRIENTINE; UNCLASSIFIED DRUG; WILSON DISEASE PROTEIN; ZINC;

AUTOSOMAL RECESSIVE DISORDER; BEHAVIOR DISORDER; BRAIN LEVEL; CERULOPLASMIN BLOOD LEVEL; CHELATION; CLINICAL FEATURE; CONCENTRATION RESPONSE; COPPER BLOOD LEVEL; COPPER LIVER LEVEL; COPPER METABOLISM; COPPER URINE LEVEL; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENZYME KINETICS; GENE IDENTIFICATION; GENE MUTATION; HETEROZYGOTE; HUMAN; LIVER DISEASE; LIVER LEVEL; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MOLECULAR GENETICS; MOTOR DYSFUNCTION; NEUROLOGICAL COMPLICATION; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION; URINE LEVEL; WILSON DISEASE;

HEPATOLENTICULAR DEGENERATION; HUMANS;

EID: 17744416816     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Gu M, Cooper JM, Butler P i sur. Oxidative-phosphorilation defects in liver of patients with Wilson's disease. Lancet 2000; 356: 469-73.
2. Scheinberg IH, Sternlieb I. Major problems in internal medicine. Vol. 23. Wilson disease. Philadelphia: WB Saunders, 1984.
3. Babić T, Relja M. Hepatocerebralna degeneracija. Lijec Vjesn 1991; 113: 348-52.
4. Chelly J, Tumer Z, Tonnesen T i sur. Isolation of a candidate gene for Menkes disease that codes a potential heavy metal binding protein. Nat Genet 1993; 3: 14-9.
5. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson's disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993; 5: 327-37.
6. Hung IH, Suzuku M, Yamaguchi Y, Yuan DS, Klausner RD, Gitlin JD. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem 1997; 272: 21461-6.
7. Yang XL, Miura N, Kawarada Y i sur. Two forms of Wilson disease protein produced by alternative splicing are localized in distinct cellular compartments. Biochem J 1997; 326: 897-902.
8. Terada K, Aiba N, Yang XL i sur. Biliary excretion of copper in LEC rat after introduction of copper transporting P-type ATPase, ATP7B. FEBS Lett 1999; 448: 53-6.
9. Petruknih K, Lutsenko S, Chernov BM, Ross JH, Kaplan TC, Gilliam TC. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase. Hum Mol Genet 1994; 3: 1647-56.
10. Firneisz G, Lakatos PL, Szalay F, Polli C, Glant TT, Ferenci P. Common mutations of ATP7Bin Wilson disease patients from Hungary. Am J Med Genet 2000; 108: 23-8.
11. Maier-Dobersberger T, Ferenci P i sur. Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med 1997; 127: 21-6.
12. Shah AB, Chernov I, Zhang HT i sur. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation and functional analysis. Am J Hum Genet 1997; 61: 317-28.
13. Loudinos G, Dessi V, Lovicu M i sur. Haplotype and mutation analysis in Greek patients with Wilson disease. Eur J Hum Genet 1998; 6: 487-91.
14. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995; 9: 210-17.
15. Agarwal K, Sharma A, Talukdar G. Effects of copper on mammalian cell components. Chem Biol Interact 1989; 69: 1-16.
16. Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28: 28-36.
17. Sheinberg IH, Sternlieb I. Wilson disease and idiopathic copper toxicosis. Am J Clin Nutr 1996; 63: 842S-5S.
18. Klomp LWJ, Lin S-J, Yuan DS, Klausner RD, Culotta VC, Gitlin JD. Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J Biol Chem 1997; 272: 9221-6.
19. Sato M, Gitlin JD. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem 1991; 266: 5128-34.
20. Harris ZL, Gitlin JD. Genetic and molecular basis for copper toxicity. Am J Clin Nutr 1996; 63: 836S-41S.
21. Linder MC, Hezeg-Azamm M. Copper biochemistry and molecular biology. Am J Clin Nutr 1996; 63: 797S-811S.
22. Smallwood RA, Williams HA, Rosenoer VM, Sherlock S. Liver-copper levels in liver disease studies using neutron activation analysis. Lancet 1968; 2: 1310-13.
23. Schilsky ML, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991; 100: 762-7.
24. Walshe JM, Yealland M. Not Wilson's disease: a review of misdiagnosed cases. Q J Med 1995; 88: 55-9.
25. Walshe JM. Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven cases. Q J Med 1989; 70: 253-63.
26. Gow PJ, Smalwood RA, Angus PW, Smith AL, Wall AJ, Sewel RB. Diagnosis of Wilson's disease: an experience over three decades. Gut 2000; 46: 415-19.
27. Lium M, Cohen EJ, Brewer GJ, Laibsom PR. Kayser-Fleischer ring as the presenting sign of Wilson disease. Am J Ophtalmol 2002; 133: 832-4.
28. Martin NF, Kincaid MC, Stark WJ i sur. Ocular copper deposition associated with pulmonary carcinoma, IgG monoclonal gammopathy and hypercupremia. Ophthalomology 1983; 90: 110-16.
29. Sanchez-Albisua I, Garde T, Hierro L i sur. A high index of suspicion: the key to an ealy diagnosis of Wilson's disease in childhood. J Pediatr Gastroenterol Nutr 1999; 28: 186-90.
30. Kolarski V. Clinico-diagnostic, therapeutic and prognostic studies of Wilson-Konovalov disease. The results of 25 years' experience. Vutr boles 1987; 26: 49-53.
31. Giacchino R, Marazzi MG, Barabino A i sur. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases. Ital J Gastroenterol Hepatol 1997; 29: 155-61.
32. Berman DH, Leventhal RI, Gavaler JS, Cardof EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100: 1129-34.
33. Scott J i sur. Wilson's disease presenting as chronic active hepatitis. Gastroenterology 1978; 74: 645-51.
34. Schilsky ML. Identification of Wilson's disease gene: clues for disease pathogenesis and the potential for molecular diagnosis. Hepatology 1994; 20: 529-33.
35. Polie J, Enriquez RE, Chow A i sur. Hepatocellular carcinoma in Wilson's disease: case report and review of the literature. J Clin Gastroenterol 1989; 11: 240.
36. Zudenigo D, Relja M. Hepatolentikularna degeneracija. Neurology 1990; 39: 115-27.
37. Van den Heuvel HN, Van der Grond J, Van Rooij LG i sur. Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson's disease: H-1 MR spectroscopy. Radiology 1997; 203: 539-43.
38. Krieger D, Krieger S, Jansen O, Gass P, Theilmamm L, Lichtneder H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346: 270-4.
39. McClure J, Smith PS. Calcium pyrophosphate dyhidrate deposition in the intervertebral discs in a case of Wilson's disease. J Clin Pathol 1983; 36: 764.
40. Steidl P, Fernci P, Dienes HP i sur. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997; 113: 212-18.
41. Walshe JM, Briggs J. Caeruloplasmin in liver disease: a diagnostic pitfall. Lancet 1962; 2: 263-5.
42. McCullough AJ, Fleming CR, Thistle JL i sur. Diagnosis of Wilson s disease presenting as a fulminant hepatic failure. Gastroenterology 1983; 84: 161-7.
43. Faa G, Nurchi V, Demelia L i sur. Uneven hepatic copper distribution in Wilson's disease. J Hepatol 1995; 24: 303.
44. Ferenci P. Wilson disease. Ind J Gastroenterol 2001; 20 (suppl 1): C71-C78.
45. McDonald JA, Snitch P, Painter D, Henle W, Gallagher ND, McCaughan GW. Striking variability in hepatic copper levels in fulminant hepatic failure. J Gastroenterol Hepatol 1992; 7: 396-8.
46. Van Wassener-Van Hall HN, Van den Hel AG, Algra A i sur. Wilson disease: findings in MR imaging and CT of the brain with clinical correlation. Radiology 1996; 198: 531-6.
47. Maier-Dobersberger T, Rack S i sur. Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology 1995; 109: 2015-18.
48. Walshe JM, Yealand M. Chelation treatment of neurological Wilson's disease. Q J Med 1993; 86: 197-204.
49. Grasedyck K. D-penicillamine-side effects, pathogenetics and decreasing the risks. Z Rheumatol 1988; 47 (SUppl a): 17-19.
50. Sheinberg IH, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Engl J Med 1987; 317: 209-13.
51. Dahlmen T, Hartvig P, Loholm M i sur. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine) Q J Med 1995; 88: 609.
52. Brewer GJ, Johnson V i sur. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 1996; 53: 1017-25.
53. Yuzbasiyan-Gurkan V, Grider A i sur. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med 1992; 120: 380-6.
54. Brewer GJ, Dick RD, Johnson V i sur. Treatment of Wilson's disease with zinc: xv. Long-term follow-up studies. J Lab Clin Med 1998; 132: 264.
55. Haberal M, Moray G, Karakayali G i sur. Liver transplantation for Wilson's cirrhosis: One centre's experience. Transplant Proc 1999; 31: 3160-1.
56. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994; 19: 583.
57. Eghtesad B, Nezakatgoo N, Geraci LC i sur. Liver transplantation for Wilson's disease: a single-centre experience. Liver Transpl Surg 1999; 5: 467-74.
58. Sutcliffe RP, Maguire DD, Muiesan P i sur. Liver transplantation for Wilson's disease: long-term results and quality-of-life assessment. Transplantation 2003; 75: 1003-6.
59. Stracciari A, Tempestini A, Borghi A i sur. Effect of liver transplantation on neurological manifestations in Wilson disease. Arch Neurol 2000; 57: 384.
60. Kreymann B, Seige M, Schweigart U i sur. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999; 31: 1080.
61. Furman B, Bashiri A, Wiznitzer A, Erez O, Holcberg G, Mazor M. Wilson's disease in pregnancy: five successful consecutive pregnancies of the same woman. Eur J Obst Gynecol Reprod Biol 2001; 96: 232-4.
62. Nazr H, Ede RJ, Mowat AP i sur. Wilson's disease: clinical presentation and use of prognostic index. Gut 1986; 27: 1377.
63. Dhawan A, D'Silv P, Taylor RM i sur. Wilson's disease in children: predictors and outcome. Thirty years experience at King's College Hospital. J Hepatol 2000; 32 (suppl 2): 136.